@article {Kumar228, author = {Munish Kumar and Karthikeyan Subramanian and Karan Singh Tanwar and Arun Prabhahar and Smita Divyaveer and Ashwani Sood and Bhagwant Rai Mittal and Apurva Sood}, title = {Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature}, volume = {50}, number = {3}, pages = {228--232}, year = {2022}, doi = {10.2967/jnmt.121.261979}, publisher = {Society of Nuclear Medicine}, abstract = {Surgical resection followed by radioactive iodine (131I) therapy constitutes a standard treatment for differentiated thyroid cancer. 131I is normally excreted through the kidneys, and treatment of patients with end-stage renal disease on hemodialysis requires special attention to the dose of 131I, the timing of dialysis, and radiation safety. We present a case of end-stage renal disease in a postthyroidectomy patient on hemodialysis who required radioactive iodine ablation, and we review the literature.}, issn = {0091-4916}, URL = {https://tech.snmjournals.org/content/50/3/228}, eprint = {https://tech.snmjournals.org/content/50/3/228.full.pdf}, journal = {Journal of Nuclear Medicine Technology} }